Skip to content
PICO Portalanswers from OpenAlex

MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis

PaperCitations, authors & open-access status

MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis is a paper indexed in PICO Portal from OpenAlex.

How many citations does MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis have?

PICO Portalcitation count

MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis has 88 citations in the OpenAlex counts PICO Portal stores.

When was MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis published?

PICO Portalyear

MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis has 2016 year in the PICO Portal index.

What is the open-access status of MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis?

PICO Portaloa status

MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis has green oa status in the PICO Portal index.

What is the DOI of MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis?

PICO Portaldoi

The DOI for MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis is on the source record.

What is the PMID of MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis?

PICO Portalpmid

The PMID for MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis is on the source record.

What is the OpenAlex record for MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis?

PICO Portalopenalex

The OpenAlex for MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial